National Health Investors, Inc. $NHI Stake Boosted by Bank of New York Mellon Corp

Bank of New York Mellon Corp boosted its holdings in National Health Investors, Inc. (NYSE:NHI) by 3.2% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 607,913 shares of the real estate investment trust’s stock after purchasing an additional 19,042 shares during the quarter. Bank of New York Mellon Corp’s holdings in National Health Investors were worth $42,627,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. MetLife Investment Management LLC lifted its position in shares of National Health Investors by 706.6% in the 1st quarter. MetLife Investment Management LLC now owns 213,730 shares of the real estate investment trust’s stock worth $15,786,000 after buying an additional 187,233 shares during the last quarter. Bowen Hanes & Co. Inc. acquired a new stake in National Health Investors during the first quarter worth about $10,340,000. Nuveen LLC bought a new position in National Health Investors in the first quarter worth about $10,126,000. Centersquare Investment Management LLC boosted its stake in National Health Investors by 25.7% in the first quarter. Centersquare Investment Management LLC now owns 495,971 shares of the real estate investment trust’s stock valued at $36,632,000 after acquiring an additional 101,538 shares during the period. Finally, Jane Street Group LLC boosted its stake in National Health Investors by 1,728.4% in the first quarter. Jane Street Group LLC now owns 69,697 shares of the real estate investment trust’s stock valued at $5,148,000 after acquiring an additional 65,885 shares during the period. 62.51% of the stock is owned by institutional investors and hedge funds.

National Health Investors Stock Performance

Shares of NHI opened at $76.21 on Thursday. The firm has a market capitalization of $3.63 billion, a PE ratio of 24.35, a P/E/G ratio of 3.31 and a beta of 0.74. The company has a quick ratio of 10.91, a current ratio of 10.91 and a debt-to-equity ratio of 0.75. The firm has a 50-day moving average price of $76.71 and a 200 day moving average price of $74.39. National Health Investors, Inc. has a 52-week low of $65.13 and a 52-week high of $81.00.

National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Thursday, November 6th. The real estate investment trust reported $1.32 earnings per share for the quarter, topping analysts’ consensus estimates of $1.24 by $0.08. The company had revenue of $83.36 million during the quarter, compared to analyst estimates of $85.66 million. National Health Investors had a net margin of 40.97% and a return on equity of 10.32%. The business’s revenue for the quarter was down 1.8% compared to the same quarter last year. During the same period in the prior year, the business posted $1.03 EPS. National Health Investors has set its FY 2025 guidance at 4.880-4.91 EPS. On average, sell-side analysts anticipate that National Health Investors, Inc. will post 4.41 earnings per share for the current fiscal year.

National Health Investors Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Wednesday, December 31st will be paid a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a yield of 4.8%. The ex-dividend date of this dividend is Wednesday, December 31st. National Health Investors’s dividend payout ratio (DPR) is presently 116.09%.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on NHI shares. National Bankshares set a $90.00 price target on National Health Investors in a research report on Wednesday, October 1st. Wells Fargo & Company raised their target price on National Health Investors from $76.00 to $80.00 and gave the company an “equal weight” rating in a research note on Wednesday, August 27th. Weiss Ratings restated a “buy (b-)” rating on shares of National Health Investors in a research report on Wednesday, October 8th. Cantor Fitzgerald assumed coverage on shares of National Health Investors in a report on Wednesday, October 1st. They issued an “overweight” rating and a $90.00 price objective on the stock. Finally, Truist Financial lifted their price objective on shares of National Health Investors from $77.00 to $81.00 and gave the company a “buy” rating in a research report on Friday, August 15th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $84.83.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.